Bisphosphonates' antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay.
about
Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BBPathophysiology of Osteonecrosis of the Jaws.Diseases having an influence on inhibition of angiogenesis as risk factors of osteonecrosis of the jaw.Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).Nitric oxide-mediated cytotoxic effect induced by zoledronic acid treatment on human gingival fibroblasts.Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.Meth Mouth—A Growing Epidemic in Dentistry?Isoprenoid geranylgeraniol: the influence on cell characteristics of endothelial progenitor cells after bisphosphonate therapy in vitro.Diabetes Mellitus and Its Association to the Occurrence of Medication-Related Osteonecrosis of the Jaw.Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases.Angiogenesis in the Development of Medication-Related Osteonecrosis of the Jaws: An Overview.Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials
P2860
Q36395911-AE114BB8-061F-4BBE-8423-C0FE49DFD193Q37006852-00BC379F-08E5-490B-8C59-A13D79DBF407Q37408215-133B19A7-9F51-47DE-8788-88C59A1FF2ACQ38970807-126E7044-9765-4F78-975A-8E69E9A2F0F6Q46820540-359751A5-A694-41AF-B055-10E92642AC70Q48969740-18D03867-8A22-49B1-9791-4CB060AA7440Q55025928-1DDB5D2B-0A9D-406B-B9E1-0285454B0FEBQ55068672-41975B80-F5EC-43C3-A088-F1C64F50A557Q55075852-1C9AB0E4-A953-4F7C-B093-E148D0F6BC63Q55094789-0C276369-5BF1-4794-AEB3-CD0BBE6DC69BQ55265048-F696ADFB-2071-4BF3-B8F7-B944373C01A0Q58791940-4074985C-BD26-43EF-9642-BA1BB25B0992
P2860
Bisphosphonates' antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Bisphosphonates' antiangiogeni ...... an in vivo 3D Matrigel assay.
@ast
Bisphosphonates' antiangiogeni ...... an in vivo 3D Matrigel assay.
@en
Bisphosphonates' antiangiogeni ...... an in vivo 3D Matrigel assay.
@nl
type
label
Bisphosphonates' antiangiogeni ...... an in vivo 3D Matrigel assay.
@ast
Bisphosphonates' antiangiogeni ...... an in vivo 3D Matrigel assay.
@en
Bisphosphonates' antiangiogeni ...... an in vivo 3D Matrigel assay.
@nl
prefLabel
Bisphosphonates' antiangiogeni ...... an in vivo 3D Matrigel assay.
@ast
Bisphosphonates' antiangiogeni ...... an in vivo 3D Matrigel assay.
@en
Bisphosphonates' antiangiogeni ...... an in vivo 3D Matrigel assay.
@nl
P2093
P2860
P1476
Bisphosphonates' antiangiogeni ...... n an in vivo 3D Matrigel assay
@en
P2093
M A Konerding
M Ackermann
P2860
P304
P356
10.1007/S00784-013-1060-X
P577
2013-07-28T00:00:00Z